Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$21.54 - $24.41 $229,401 - $259,966
10,650 Added 6.83%
166,594 $3.77 Million
Q2 2023

Aug 11, 2023

BUY
$12.62 - $24.47 $629,674 - $1.22 Million
49,895 Added 47.05%
155,944 $3.82 Million
Q1 2023

May 15, 2023

BUY
$12.98 - $17.1 $1.21 Million - $1.6 Million
93,346 Added 734.83%
106,049 $1.43 Million
Q3 2022

Nov 14, 2022

BUY
$13.36 - $16.75 $21,589 - $27,068
1,616 Added 14.58%
12,703 $190,000
Q2 2021

Aug 13, 2021

BUY
$18.47 - $22.11 $204,776 - $245,133
11,087 New
11,087 $211,000

Others Institutions Holding ABCM

About Abcam plc


  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.